China-based gene testing service providers Tongshu Gene and LC Gene Diagnostics (Hangzhou) Co., Ltd. have entered into a strategic partnership, under which Tongshu Gene will become the exclusive distributor of LC Gene’s human EGFR, BRAF, KRAS, ALK, and ROS1 gene mutation detection kit. The agreement leverages LC Gene’s proprietary technology to enhance the precision and efficiency of genetic testing in China. Financial terms of the deal were not disclosed.
LC Gene’s Technological Edge
LC Gene’s gene mutation detection kit features a proprietary multiple PCR gene capture technology that enables one-step, accurate capture of target genes. This innovation simplifies laboratory procedures and reduces the risk of sample contamination, making it a valuable tool for genetic diagnostics. Additionally, LC Gene has integrated molecular tag technology into its platform for the first time. By using connectors with molecular tags, the technology corrects errors caused by PCR amplification bias, thereby improving the quality of database construction and enhancing the accuracy of sequencing results.
Market Potential and Strategic Impact
The partnership between Tongshu Gene and LC Gene Diagnostics underscores the growing demand for advanced genetic testing solutions in China. As precision medicine continues to gain traction, the ability to detect and analyze gene mutations accurately is becoming increasingly critical. This collaboration aims to expand the reach of LC Gene’s innovative testing kit, providing healthcare providers with a reliable tool to guide personalized treatment decisions for patients with cancer and other genetic disorders.-Fineline Info & Tech
